HPV in Males/Females

Understanding HPV Epidemiology, Diseases, and Vaccines in Male and Female Patients

Program Overview

Primary care clinicians are at the frontline of vaccination to protect women against HPV; gynecologists are traditionally not ones to provide vaccines. Primary care providers most often do not think of HPV and sexually transmitted infections (STI), often leaving them to annual gynecologic examinations. Together, these factors have led to poor vaccination rates with what is deemed a critical vaccine for women by the CDC. Data indicate gaps exist regarding HPV knowledge among clinicians, and this encompasses areas as diverse as HPV epidemiology, transmission, and risks to specific populations.

The entire medical community has largely overlooked HPV in men, as men are far less likely to be symptomatic of infection than women. It is only recently that new literature is being published highlighting the increasing rates of HPV-related disease in men including genital warts, anal cancer, and head and neck cancer. Little is known by clinicians about HPV transmission, epidemiology, and burden of disease in men; moreover, HPV infection in men does not decrease with age as it does in women. We will illustrate our learning objectives with data from peer-reviewed journals and hopefully create a better understanding of this emerging health problem among primary care physicians. Ultimately, we hope to influence the standard of care.

Learning Objectives

After completing this activity, the participant should be better able to

  1. Screen and identify high-risk patients for HPV-related diseases
  2. Provide education to patients regarding HPV infection and transmission, its risks, and impact on clinical outcomes
  3. Follow guidelines for administering prophylactic HPV vaccines to male and female patients

Accreditation/Designation Statement

Primary Care Network is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Target Audience: This activity is targeted to all physicians and other healthcare professionals who treat patients.

Release Date: March 4, 2011
Expiration Date: March 4, 2012

Medium: Online CME (slides/audio)

Acknowledgment of Commercial Support

This activity was developed from the live Best Practices in Primary Care™ program held in Anaheim, California, on November 16, 2010, and is funded by Merck & Company.

Method of Participation

To receive CME credit for this activity, participant must read the CME information (including the learning objectives and disclosures) and review the entire activity (slides and audio). After finishing the activity, participant must complete the post-test, evaluation, and all required personal information. To receive CME certificate participant will need to pass the post-test with 70% accuracy or better.

Post-test and Evaluation

After completing this activity, participant should click on the Post-test button at the end of the activity. If participant receives less than 70% on the post-test, participant should return to the beginning of the activity to review the activity again. After successful completion of the post-test, participant will be asked to fill out an evaluation form and prompted to print the CME certificate. Participant should PLEASE be ready to print certificate at this time.

Statement of Disclosure and Independence

It is the policy of Primary Care Network (PCN) to ensure all its sponsored educational activities are planned, developed, and conducted in accordance with the ACCME’s Essential Areas and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest and Disclosure Policies that are designed to ensure that PCN sponsored educational activities are fair balanced, independent, evidence-based, and based on scientific rigor.

Primary Care Network’s Resolution of Personal Conflicts of Interest (COI) Policy aims to ensure that all conflicts are resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN sponsored activity are required to disclose to the participants any real or apparent conflict of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent external clinical reviewer and internal clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

The opinions, ideas, recommendations, and perspectives expressed in the accompanying presentations in this Primary Care Education activity are those of the activity authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations, or perspectives of their affiliated institutions, Primary Care Network, Primary Care Education, Advisory Boards and Consultants, or the activity’s commercial supporters.

Faculty and Disclosures

Heidi Bauer, MD, MPH, MS
Chief
Program Development and Evaluation Section
California Department of Public Health
STD Control Program
Medical Co-Director
California STD/HIV Prevention Training Center
Richmond, California

Dr. Bauer has no relevant financial relationships to disclose.

Stephen Goldstone, MD
Assistant Clinical Professor of Surgery
The Mount Sinai School of Medicine
Fellow of the American College of Surgeons
New York, New York

Dr. Goldstone is on the speaker’s bureau, advisory board, and is a consultant for Merck; he has received research grants from the AIDS Malignancy Consortium, Merck, and Qiagen.

Planning Committee and Disclosures

Stephen Goldstone, MD
Assistant Clinical Professor of Surgery
The Mount Sinai School of Medicine
Fellow of the American College of Surgeons
New York, New York

Dr. Goldstone is on the speaker’s bureau, advisory board, and is a consultant for Merck; he has received research grants from the AIDS Malignancy Consortium, Merck, and Qiagen.

Gary Richwald, MD, MPH
Medical Advisor
LA and Orange County HSV & HPV support groups
Former Medical Director
Los Angeles County STD Program
Los Angeles, California

Dr.  Richwald is on the speakers’ bureaus for GlaxoSmithKline and Merck.

Fred Wyand
American Social Health Association (ASHA)
Manager, National HPV Resource Center
Research Triangle Park, North Carolina

Mr. Wyand has no relevant financial relationships to disclose.

Amy Huang
American Social Health Association (ASHA)
Senior Project Manager
Research Triangle Park, North Carolina

Ms. Huang has no relevant financial relationships to disclose.

Review Committee Disclosure

In accordance with PCN policy, all content is reviewed by external independent peer reviewers for balance, objectivity, and commercial bias.  The peer reviewers, staff, and other individuals who control content have no relevant financial relationships to disclose.

Unlabeled Use Declaration

During their presentation(s), faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

This activity has expired and is no longer available for CME; however, we hope you still enjoy the education.

If you are using a mobile device, this activity may not view properly.

Attachments

Bibliography

Generic to Brand Name Drug Table